|
|
|
|
|
|
|
|
|
25.11.25 - 08:33
|
XFRA: EKW0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
PSYENCE GROUP INC. NEW EKW0 CA74449Q2053 BAW/UFN...
|
|
|
|
|
|
|
|
|
17.10.25 - 22:18
|
Psyence Group Inc. Announces RSU Grants (Accesswire)
|
|
|
TORONTO, ON / ACCESS Newswire / October 17, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it granted an aggregate of 721,448 restricted share units (each an "RSU......
|
|
|
22.08.25 - 18:36
|
XFRA: EKW0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
PSYENCE GROUP INC. NEW EKW0 CA74449Q2053
AB/FROM ONWARDS 22.08.2025 18:33 CET...
|
|
|
|
|
|
|
|
|
|
|
18.06.25 - 23:39
|
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares (GlobeNewswire EN)
|
|
|
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing is pleased to announce an offering of a non-brokered private placement (the “Offering”) of up to 6,000,000 common shares of the Company (the “Common Shares”) at a price of C$0.10 per Common Share for gross proceeds of up to C$600,000. No finder's fees or commissions will be payable in connection with the Offering....
|
|
|
|
|
|
|
23.04.25 - 09:06
|
XFRA: 8VC0,BC21,EKW0,1S90: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
GREAT PLAINS MET. O.N. 8VC0 CA3911731014 BAW/UFN
MAGMA SILVER CORP. BC21 CA5589221004 BAW/UFN
PSYENCE GROUP INC. NEW EKW0 CA74449Q2053 BAW/UFN
SERES THERA.NEW DL -,001 1S90 US81750R2013 BAW/UFN...
|
|
|
22.04.25 - 16:39
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA00833F3079 African Energy Metals Inc. 22.04.2025 CA5589221004 Magma Silver Corp. 23.04.2025 Tausch 1:1
CA74449Q1063 Psyence Group Inc. 22.04.2025 CA74449Q2053 Psyence Group Inc. 23.04.2025 Tausch 15:1
CA65651T1012 Great Plains Metals Corp. 22.04.2025 CA3911731014 Great Plains Metals Corp. 23.04.2025 Tausch 1:1
US81750R1023 Seres Therapeutics Inc. 22.04.2025 US81750R2013 Seres Therapeutics Inc. 23.04.2025 Tausch 20:1
CA5015067039 KWESST Micro Systems Inc. 22.04.2025 CA5015068029 KWESST Micro Systems Inc. 23.04.2025 Tausch 21:1
FI4000369657 Glaston Oyj 22.04.2025 FI4000587340 Glaston Oyj 23.04.2025 Tausch 2:1...
|
|